Tag | Content |
---|
EnhancerAtlas ID | HS182-09896 |
Organism | Homo sapiens |
Tissue/cell | Spleen |
Coordinate | chr17:73339610-73341250 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Myod1 | MA0499.1 | chr17:73340952-73340965 | AGCAGCTGTTACT | + | 6.52 | RREB1 | MA0073.1 | chr17:73340910-73340930 | CCCCAACCCCCCACACCCCC | + | 6.16 | RREB1 | MA0073.1 | chr17:73340925-73340945 | CCCCCTCCCAACCCCCCCGC | + | 6.52 | RREB1 | MA0073.1 | chr17:73340915-73340935 | ACCCCCCACACCCCCTCCCA | + | 6.86 | TBXT | MA0009.2 | chr17:73339700-73339716 | TCACACTTATGTGATA | + | 6.05 | TBXT | MA0009.2 | chr17:73339700-73339716 | TCACACTTATGTGATA | - | 6.19 | ZNF263 | MA0528.1 | chr17:73339913-73339934 | AAAGGAGAGGAAGGGAGGGGG | + | 6.07 | ZNF263 | MA0528.1 | chr17:73339906-73339927 | GGAGAAGAAAGGAGAGGAAGG | + | 6.87 | Zfx | MA0146.2 | chr17:73340716-73340730 | CCCGCCTCGGCCTC | + | 6.01 |
|
| Number of super-enhancer constituents: 10 | ID | Coordinate | Tissue/cell |
SE_09177 | chr17:73334036-73349163 | CD14 | SE_10509 | chr17:73334088-73345751 | CD19_Primary | SE_11413 | chr17:73324621-73349939 | CD20 | SE_14041 | chr17:73341081-73342136 | CD34_Primary_RO01536 | SE_18858 | chr17:73335882-73340913 | CD4p_CD25-_Il17-_PMAstim_Th | SE_25706 | chr17:73334095-73345615 | DND41 | SE_54131 | chr17:73339596-73340419 | Spleen | SE_54131 | chr17:73340449-73341087 | Spleen | SE_61022 | chr17:73284104-73345918 | HBL1 | SE_62513 | chr17:73287335-73369120 | Tonsil |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 3 | Chromosome | Start | End |
chr17 | 73339859 | 73339959 | chr17 | 73340000 | 73340600 | chr17 | 73340912 | 73341078 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH17I075334 | chr17 | 73330718 | 73345080 |
|
Enhancer Sequence | TAACTAGGAT ATGCTCATCA ACCTCTTCAG TTGACCTCTT ATCATCAAGA GAAATTGCTC 60 TTGATATTTT TAACAAAACA GGAAGGTAGT TCACACTTAT GTGATATTAC TCCACCCAGA 120 TAAATCTGGA GGCAGTGAAA CCTAAATGCA TAGACAAACC CCAAAATAAA CTTCTACCAA 180 AGGGGTACAA AAAGTTTCCA TTCAAAATAA CTGTCTTGCG TTTTGTGACA TGTGGAAGTC 240 CTATTTGGTG GAGCTGAAAT GCTCTTGGAA TGTCAGAATT TCAACTGCAC GAGCAGGGAG 300 AAGAAAGGAG AGGAAGGGAG GGGGCAGGAA GAGACCAACA CAGAGATCAA GAGGTTTCAA 360 GAAAAATCTG TGTATTTGAA AAATTCAACA ATCATATGAT GACCTGTACT AGACAAACAC 420 CAAGCCCTGG GCTAGGTGAA CTGAGGATAA AATGGATACC CTTCCCAAGG AGCTTAGGGG 480 ACTAGAAAGC TGCCAGGTGC ATCACAGTGT GACGAATGTC AGGAGTGGGG AGTTATGGGT 540 ACTATGTAGG CATCAATTCA ATAGAAAACA TCTGACTTCC AAACACCAAA GACGATGACT 600 TAACTCCAGG TTAGGGGGTA TCAGGAAAAC ATCCTAGATG AAGTGTGAAC TTGGTTATTC 660 CCTGTCTGCA TCTTTAGCTC TGCTTAGTCT GTGTGGACTG TGAGTAGAAG GAACATGGCA 720 GACTCTGCAA GTAGACAGAT TGTTGTTTGG CTGCTATTAA CTAAAACACT GGTTAAGCTT 780 CTTTTAGCTT AAAGGTAAAA TATTTATTAA TGGTATCAGA ACTTCTAACT GGAAATAACC 840 TAAATAACCT CAACTGTAGC TAATTTTTTT TTTTTTTTTT CAGACAGAGT CTTGCTTTTG 900 TTGCCCAGGC TGGAGTGCAA TGGCGTGATC TCAGCTCACT GCAACCTCCA CCTCCCGGGT 960 TCAAGCGATT CTCCTGCCTC AACCTCCTGA GTAGCTGGGA TTACAGGTGC CTGCCACCAA 1020 GCTGGCTAAT TTCTATATTT TCAGTACAGA CAGGGTTTCA TCAAGTTGGC CAGGCTGGTG 1080 TTGAACTCCT GAGTTCAAGT GATCTGCCCG CCTCGGCCTC CCAAAGTGCC AGGATTTACA 1140 GGTGTTGAGC CACCGCGCTC GGCCTCAACT GTAGCTAATT CTTTACTTTA ATGACACATA 1200 TTTAGCAACT GTCCTTTTCA TCCTTTCACT AACAGAAGGA GGCTTTTAAT CTTACATGAA 1260 ATCCTACACT CCTCTCTTCA AAAAATAAAA CACAAAGCCT CCCCAACCCC CCACACCCCC 1320 TCCCAACCCC CCCGCCTGGG GGAGCAGCTG TTACTCATGT TTTGTGATGC TAACAGGCAA 1380 ACCCGCTCCT GTGTGTCAGT TCCACCCTCT AAGGTCTCCA CTCACTTCCC ACTGCCTCAG 1440 CATAAAGCAG AAAACAGGAG CTCAAACCTC TACCCTGAAA ATTAATGACA ACAGAGGTTT 1500 TTTTTTAAAT TTTATTTATT ATTATTATTT TTGAGATGGA GTCTTGCTCT GTCCCCCAGG 1560 CTGGAGTGCA GTGGCGCAAT CTCGGCTCAC TGCAACCTCC GCTCCTGGGT TCATCCCATT 1620 CTCCTGCCTC AGCCTCCTGA 1640
|